Growth arrest-specific protein 6
ProteinGrowth factor involved in hair follicle signalling and cellular processes relevant to hair cycle regulation.
Where beauty meets biology
Growth factor involved in hair follicle signalling and cellular processes relevant to hair cycle regulation.
The community of gut microorganisms that modulates immune signalling, inflammation, and microbial metabolites with downstream effects on skin barrier function and disease risk.
The bidirectional communication system linking gut microbiota, immune signalling, and microbial metabolites to skin inflammation, barrier function, and disease susceptibility.
Complex miniature organs embedded in the dermis and subcutis that cycle through growth (anagen), transition (catagen), and rest (telogen) phases throughout life.
Umbrella term for conditions causing increased hair shedding or thinning, ranging from temporary telogen effluvium to progressive androgenetic alopecia.
A framework of twelve interconnected biological processes - organised into Primary, Antagonistic, and Integrative tiers - that collectively produce the structural decline of ageing tissue.
Water with elevated dissolved calcium and magnesium content. Disrupts skin barrier function through four mechanistically independent pathways.
Non-GI side effect of tirzepatide showing significant variation by injection site, with thigh injection reducing incidence by nearly half.
Glycosaminoglycan-bearing proteins distributed across the dermal ECM and basement membrane that store and regulate growth factors including FGF2, FGF7, FGF10, and VEGF in a protected on-site depot.
Dietary pattern of elevated sugar and processed food intake that leads to increased blood glucose and potential skin effects.
An essential amino acid with a uniquely skin-specific metabolic pathway. Filaggrin is particularly rich in histidine, and its degradation converts histidine to trans-urocanic acid.
A glycosaminoglycan that forms the water-retaining ground substance of the dermis and maintains the mechanical environment fibroblasts need for collagen synthesis.
Hyaluronic acid lip fillers are injectable cross-linked HA gels used to augment lip volume, define the vermilion border, and restore lip proportion lost through ageing or asymmetry.
Hyperpigmentation describes the localised or diffuse overproduction or abnormal distribution of melanin in the skin. It is not a single condition but three mechanistically distinct presentations.
The body’s central stress‑response system, driving CRH→ACTH→cortisol signalling systemically and via a parallel cutaneous HPA axis that regulates skin immunity, barrier function, and repair.
The ileal brake is a physiological feedback mechanism by which unabsorbed nutrients in the small intestine triggers the release of satiety hormones that suppress appetite.
Chronic low-grade sterile inflammation accumulating with age through senescence, cGAS-STING, and NF-κB amplification — impairing tissue repair and driving structural skin ageing.
Low-spin blood preparation preserving platelets, leucocytes, and stem cells within a fibrin matrix that sustains growth factor release over 7-14 days.
A β‑cell–derived anabolic hormone that regulates glucose uptake, lipid storage, and tissue growth, with chronic hyperinsulinaemia producing metabolic effects before overt hyperglycaemia.
A state of reduced insulin responsiveness driven by DAG–PKC signalling and impaired fuel switching, linking metabolic overload to systemic glucose dysregulation.
The PI3K–AKT signalling pathway triggered by insulin receptor activation that drives glucose uptake, suppresses hepatic glucose output, and restrains adipose lipolysis.
A growth factor produced primarily by dermal fibroblasts and dermal papilla cells, with roles spanning fibroblast proliferation, keratinocyte migration, collagen stabilisation, and angiogenesis.
The body's outermost organ system, comprising the skin and its appendages: hair, nails, sebaceous glands, and sweat glands.
Inflammatory cytokine that suppresses production of barrier proteins including filaggrin and claudin-1.
IL‑33 is an epithelial‑derived “alarmin” cytokine released from stressed or damaged barrier tissues, including keratinocytes in the skin.
Inflammatory cytokine that suppresses barrier protein production, perpetuating barrier dysfunction during inflammatory skin conditions.
A pleiotropic cytokine with context-dependent pro- and anti-inflammatory effects determined by which receptor complex mediates signalling.
A fructooligosaccharide prebiotic fermented by S. epidermidis to support SCFA‑driven acidification, AMP tone, and barrier integrity while forming a hygroscopic film that reduces TEWL.
Topical actives that trigger TRP‑channel‑mediated neurogenic inflammation to produce transient lip swelling; effects are short‑lived and increase barrier disruption with repeated use.
A trypsin-like serine protease expressed by keratinocytes that acts as the master initiating enzyme of epidermal desquamation.